Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, FDA

MyHomeDoc Announces Rebrand as NONAGON - Reflecting Commitment To Make Healthcare Accessible To All


RAANANA, Israel, April 27, 2021 /PRNewswire/ -- Today, medical start-up MyHomeDoc announced that its brand name will from now on be known as NONAGON. The new branding will begin effective immediately on all products, digital assets, and communications worldwide.

The NONAGON name refers to a nine-sided polygon. In a literal sense, the NONAGON name alludes to the nine physical exams that the N9 device can conduct in conjunction with a regular smartphone. Additionally, the NONAGON brand name symbolizes the inner meaning that is ascribed to the number nine throughout the world, which, in many cultures and traditions, is regarded as a numeric conduit for personal fulfillment and spiritual and physical good fortune.

The nine physical exams that are conducted with the NONAGON N9 device enable telehealth providers to raise the bar higher. The medical-grade patient exams, conducted remotely, help to increase physician confidence in remote diagnosis, and, moreover, allow patients and physicians to follow up and monitor the patients' ongoing clinical measurements?an advantage that can help confirm the chosen medical pathway.

NONAGON's N9 device is FDA cleared, CE marked and approved by the Israeli Ministry of Health (AMAR).  For patients, the device is compact, cost-friendly, and easy to use along with the associated smartphone app. For physicians, NONAGON makes it possible to make clinical decisions remotely based on clinically valid data. For Health Care Systems, NONAGON makes it possible to reach out to more patients and make healthcare more accessible to everyone, everywhere.

"The company was founded in 2016 with a dream to elevate the telehealth process and make it more accessible for everyone. As part of that vision, the N9 device was developed to be simple-to-use, yet robust, financially efficient, and state-of-the-art," according to CEO Alon Natanson, "the new NONAGON brand aligns with our core values and motivations that include giving patients and physicians the peace of mind that comes with knowing they are in control by adding validated clinical data to their telehealth experience. We believe that NONAGON's potential to make healthcare more convenient and accessible is the innovation for which the telehealth industry has been waiting."

The new NONAGON brand identity expresses a novel approach to healthcare. By welcoming patients to a range of affordable, high-quality healthcare services, NONAGON represents an open portal to 24/7 healthcare for patients. The NONAGON product and brand identity are based on the image of a trusted member of the family who is always there and always willing to help. The brand tagline, "care at hand," is a double entendre that refers to the system's ease of use as well as its ability to make high-quality healthcare more convenient and accessible.

You can reach us for more details: [email protected].

NONAGON is participating this week in the ACP - Internal Medicine Meeting 2021. Come see us at our virtual booth, or schedule a time to learn about the NONAGON solution, and also watch our live demonstration with doxy.me showing how our technologies can work synergistically to make telehealth better.

Follow us on LinkedIn

Contact: Omer Maman, VP Marketing & Products
[email protected]

 

SOURCE NONAGON


These press releases may also interest you

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...



News published on and distributed by: